AGENUS INC — Director's Dealing 2010

Apr 2, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANTIGENICS INC /DE/ (agen)
CIK: 0001098972
Period of Report: 2010-04-01

Reporting Person: DECHAENE TOM (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-04-01	Deferred Shares	$	A	3708.501	Acquired		Common Stock (3708.501)	Direct

Footnotes

F1: Acquired under the Antigenics Directors' Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of shares of the Company's common stock to be distributed with the terms of the Plan, typically once the director ceases to serve as a director of the Company.